Clinical Diagnosis

Andrew G. Lee, MD, and Drew Carey, MD, break down the link between optic neuritis and uveitis in central nervous system demyelinating disease.

Prevent Blindness marks IED Week, October 19 to 25, as new therapies and pivotal trials reshape care for uveitis and thyroid eye disease.

The nonprescription 0.125% apraclonidine drop is approved for adults and children 12 years and older, and Alcon says each dose whitens the eye for up to 12 hours.

Noab Banoub, a third year medical student, describes his journey into medicine and his view of ophthalmology's future.

Uveitis is uncommon, but it causes a disproportionate share of visual morbidity.

As with so many diseases, lung cancer manifests in men and women differently in type, symptoms, and prognosis.

Women’s systemic and ocular health associated with pregnancy is a focus at EURETINA 2026 in Vienna.

Inherited metabolic diseases affect the retina even before the systemic diagnosis is established.

Women are more often affected than men, and the disease manifests differently between the sexes.

Sight Sciences' newest MIGS device gains FDA clearance for single-pass canaloplasty and trabeculotomy in open-angle glaucoma.

This article discusses the current treatments being investigated during the first half of 2026.

Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.

Ophthalmology Times® On Air

Optical coherence tomography angiography found distinctive microvascular signatures in the retinal layers associated with various stages of decline in cognition.

Andrew G. Lee, MD, and Drew Carey, MD, review how clinical and imaging findings relate to vision recovery after radiotherapy for optic nerve sheath meningioma.

The University of Rochester’s Flaum Eye Institute is embedding behavioral health into ophthalmology to improve patient care and clinician support.

Immediate flushing of the eye can significantly reduce long-term damage after chemical exposure.

Chiesi Global Rare Diseases said the agency declined to approve its application and requested additional information for the proposed treatment of Leber hereditary optic neuropathy.

The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

Clinicians emphasize screening, individualized care, and recognition of sex-based differences to prevent vision-threatening complications

Clear counseling and tailored lens choice reduce postoperative dissatisfaction

Large study links specific retinal findings to leukemia subtype, predicting remission risk and visual prognosis—prompt eye exams can flag relapse early.

Retina experts unpack MacTel type 2—spot subtle signs, understand anti-VEGF limits, and explore emerging neuroprotective treatments.